Henan Taloph Pharmaceutical Stock Co.,Ltd (SHA: 600222)

Henan Taloph Pharmaceutical Stock Co.,Ltd Statistics

Total Valuation

Henan Taloph Pharmaceutical Stock Co.,Ltd has a market cap or net worth of CNY 3.18 billion. The enterprise value is 3.81 billion.

Market Cap	3.18B
Enterprise Value	3.81B

Important Dates

The next estimated earnings date is Thursday, March 27, 2025.

Earnings Date	Mar 27, 2025
Ex-Dividend Date	Dec 9, 2024

Share Statistics

Henan Taloph Pharmaceutical Stock Co.,Ltd has 554.67 million shares outstanding. The number of shares has decreased by -1.13% in one year.

Current Share Class	n/a
Shares Outstanding	554.67M
Shares Change (YoY)	-1.13%
Shares Change (QoQ)	-0.69%
Owned by Insiders (%)	2.31%
Owned by Institutions (%)	5.85%
Float	403.13M

Valuation Ratios

The trailing PE ratio is 35.72.

PE Ratio	35.72
Forward PE	n/a
PS Ratio	1.62
PB Ratio	2.02
P/TBV Ratio	2.58
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 21.57, with an EV/FCF ratio of -163.68.

EV / Earnings	42.63
EV / Sales	1.94
EV / EBITDA	21.57
EV / EBIT	35.79
EV / FCF	-163.68

Financial Position

The company has a current ratio of 1.07, with a Debt / Equity ratio of 0.61.

Current Ratio	1.07
Quick Ratio	0.75
Debt / Equity	0.61
Debt / EBITDA	5.55
Debt / FCF	-42.11
Interest Coverage	1.88

Financial Efficiency

Return on equity (ROE) is 6.06% and return on invested capital (ROIC) is 2.75%.

Return on Equity (ROE)	6.06%
Return on Assets (ROA)	1.88%
Return on Capital (ROIC)	2.75%
Revenue Per Employee	836,257
Profits Per Employee	37,985
Employee Count	2,353
Asset Turnover	0.56
Inventory Turnover	2.91

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -12.44% in the last 52 weeks. The beta is 0.65, so Henan Taloph Pharmaceutical Stock Co.,Ltd's price volatility has been lower than the market average.

Beta (5Y)	0.65
52-Week Price Change	-12.44%
50-Day Moving Average	5.25
200-Day Moving Average	4.85
Relative Strength Index (RSI)	60.26
Average Volume (20 Days)	17,997,648

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Henan Taloph Pharmaceutical Stock Co.,Ltd had revenue of CNY 1.97 billion and earned 89.38 million in profits. Earnings per share was 0.16.

Revenue	1.97B
Gross Profit	551.71M
Operating Income	106.46M
Pretax Income	88.37M
Net Income	89.38M
EBITDA	160.05M
EBIT	106.46M
Earnings Per Share (EPS)	0.16

Balance Sheet

The company has 397.75 million in cash and 980.46 million in debt, giving a net cash position of -582.70 million or -1.05 per share.

Cash & Cash Equivalents	397.75M
Total Debt	980.46M
Net Cash	-582.70M
Net Cash Per Share	-1.05
Equity (Book Value)	1.62B
Book Value Per Share	2.83
Working Capital	148.33M

Cash Flow

In the last 12 months, operating cash flow was -287,513 and capital expenditures -22.99 million, giving a free cash flow of -23.28 million.

Operating Cash Flow	-287,513
Capital Expenditures	-22.99M
Free Cash Flow	-23.28M
FCF Per Share	-0.04

Margins

Gross margin is 28.04%, with operating and profit margins of 5.41% and 4.54%.

Gross Margin	28.04%
Operating Margin	5.41%
Pretax Margin	4.49%
Profit Margin	4.54%
EBITDA Margin	8.13%
EBIT Margin	5.41%
FCF Margin	-1.18%

Dividends & Yields

This stock pays an annual dividend of 0.02, which amounts to a dividend yield of 0.32%.

Dividend Per Share	0.02
Dividend Yield	0.32%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	79.43%
Buyback Yield	1.13%
Shareholder Yield	1.45%
Earnings Yield	2.80%
FCF Yield	-0.73%

Stock Splits

The last stock split was on May 12, 2010. It was a forward split with a ratio of 1.3.

Last Split Date	May 12, 2010
Split Type	Forward
Split Ratio	1.3

Scores

Henan Taloph Pharmaceutical Stock Co.,Ltd has an Altman Z-Score of 1.61. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.61
Piotroski F-Score	n/a